SCHEMBL15536552

SCHEMBL15536552

CS(=O)(=O)NC(=O)c1cc(C2CC2(F)F)c(OCC23CC4CC(CC(C4)C2)C3)cc1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 1.00
SCN5A Q14524 4/20 0.82
SCN7A Q01118 2/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15537023 0.90 SCN9A (1.00) SCN9ASCN5ASCN7A
SCHEMBL16387234 0.89 SCN9A (1.00) SCN9ASCN5ASCN7A
SCHEMBL15535911 0.88 SCN9A (0.93) SCN9ASCN5ASCN7A
SCHEMBL15536451 0.88 SCN9A (1.00) SCN9ASCN5ASCN7A
SCHEMBL15535927 0.88 SCN9A (1.00) SCN9ASCN5A
SCHEMBL15536899 0.87 SCN9A (1.00) SCN9ASCN5ASCN7A
SCHEMBL16448576 0.86 SCN9A (1.00) SCN9ASCN5ASCN7A
SCHEMBL15536872 0.86 SCN9A (0.82) SCN9ASCN5ASCN7A
SCHEMBL15536740 0.86 SCN9A (1.00) SCN9ASCN5ASCN7A
SCHEMBL15537703 0.86 SCN9A (1.00) SCN9ASCN5ASCN7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US claimed
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 EP disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 WO disclosed